286 related articles for article (PubMed ID: 36689079)
1. Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression.
de-Souza-Ferreira M; Ferreira ÉE; de-Freitas-Junior JCM
Cell Oncol (Dordr); 2023 Jun; 46(3):481-501. PubMed ID: 36689079
[TBL] [Abstract][Full Text] [Related]
2. Altered β1,6-GlcNAc and bisecting GlcNAc-branched N-glycan on integrin β1 are associated with early spontaneous miscarriage in humans.
Zhang M; Wang M; Gao R; Liu X; Chen X; Geng Y; Ding Y; Wang Y; He J
Hum Reprod; 2015 Sep; 30(9):2064-75. PubMed ID: 26109616
[TBL] [Abstract][Full Text] [Related]
3. Diverse expression of N-acetylglucosaminyltransferase V and complex-type β1,6-branched N-glycans in uveal and cutaneous melanoma cells.
Pocheć E; Rydlewska M; Przybyło M; Lityńska A
Acta Biochim Pol; 2015; 62(2):323-8. PubMed ID: 26098720
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAcylation regulates β1,4-GlcNAc-branched N-glycan biosynthesis via the OGT/SLC35A3/GnT-IV axis.
Song W; Isaji T; Nakano M; Liang C; Fukuda T; Gu J
FASEB J; 2022 Feb; 36(2):e22149. PubMed ID: 34981577
[TBL] [Abstract][Full Text] [Related]
5. Functional roles of the bisecting GlcNAc in integrin-mediated cell adhesion.
Isaji T; Kariya Y; Xu Q; Fukuda T; Taniguchi N; Gu J
Methods Enzymol; 2010; 480():445-59. PubMed ID: 20816221
[TBL] [Abstract][Full Text] [Related]
6. N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells.
Morgan R; Gao G; Pawling J; Dennis JW; Demetriou M; Li B
J Immunol; 2004 Dec; 173(12):7200-8. PubMed ID: 15585841
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein glycosylation and cancer progression.
Dennis JW; Granovsky M; Warren CE
Biochim Biophys Acta; 1999 Dec; 1473(1):21-34. PubMed ID: 10580127
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of N-acetylglucosaminyltransferases III and V in human melanoma cells. Implications for MCAM N-glycosylation.
Bubka M; Link-Lenczowski P; Janik M; Pocheć E; Lityńska A
Biochimie; 2014 Aug; 103():37-49. PubMed ID: 24726881
[TBL] [Abstract][Full Text] [Related]
9. T cell receptor signaling co-regulates multiple Golgi genes to enhance N-glycan branching.
Chen HL; Li CF; Grigorian A; Tian W; Demetriou M
J Biol Chem; 2009 Nov; 284(47):32454-61. PubMed ID: 19706602
[TBL] [Abstract][Full Text] [Related]
10. UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,6 N-acetylglucosaminyltransferase V (Mgat5) deficient mice.
Dennis JW; Pawling J; Cheung P; Partridge E; Demetriou M
Biochim Biophys Acta; 2002 Dec; 1573(3):414-22. PubMed ID: 12417426
[TBL] [Abstract][Full Text] [Related]
11. Altered β1,6-GlcNAc branched N-glycans impair TGF-β-mediated epithelial-to-mesenchymal transition through Smad signalling pathway in human lung cancer.
Li N; Xu H; Fan K; Liu X; Qi J; Zhao C; Yin P; Wang L; Li Z; Zha X
J Cell Mol Med; 2014 Oct; 18(10):1975-91. PubMed ID: 24913443
[TBL] [Abstract][Full Text] [Related]
12. Golgi N-glycan branching N-acetylglucosaminyltransferases I, V and VI promote nutrient uptake and metabolism.
Abdel Rahman AM; Ryczko M; Nakano M; Pawling J; Rodrigues T; Johswich A; Taniguchi N; Dennis JW
Glycobiology; 2015 Feb; 25(2):225-40. PubMed ID: 25395405
[TBL] [Abstract][Full Text] [Related]
13. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity.
Yamamoto H; Swoger J; Greene S; Saito T; Hurh J; Sweeley C; Leestma J; Mkrdichian E; Cerullo L; Nishikawa A; Ihara Y; Taniguchi N; Moskal JR
Cancer Res; 2000 Jan; 60(1):134-42. PubMed ID: 10646865
[TBL] [Abstract][Full Text] [Related]
14. Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V.
Lee JK; Matthews RT; Lim JM; Swanier K; Wells L; Pierce JM
J Biol Chem; 2012 Aug; 287(34):28526-36. PubMed ID: 22715095
[TBL] [Abstract][Full Text] [Related]
15. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
Taniguchi N; Kizuka Y
Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
[TBL] [Abstract][Full Text] [Related]
16. Expression of integrins α3β1 and α5β1 and GlcNAc β1,6 glycan branching influences metastatic melanoma cell migration on fibronectin.
Pocheć E; Janik M; Hoja-Łukowicz D; Link-Lenczowski P; Przybyło M; Lityńska A
Eur J Cell Biol; 2013 Dec; 92(12):355-62. PubMed ID: 24290991
[TBL] [Abstract][Full Text] [Related]
17. The cancer-associated glycosyltransferase GnT-V (MGAT5) recognizes the N-glycan core via residues outside its catalytic pocket.
Osuka RF; Nagae M; Ohuchi A; Ohno S; Yamaguchi Y; Kizuka Y
FEBS Lett; 2023 Dec; 597(24):3102-3113. PubMed ID: 37974463
[TBL] [Abstract][Full Text] [Related]
18. Recognition of glycan and protein substrates by N-acetylglucosaminyltransferase-V.
Hirata T; Nagae M; Osuka RF; Mishra SK; Yamada M; Kizuka Y
Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129726. PubMed ID: 32890705
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of Mgat5 inhibits breast cancer cell growth with activation of CD4+ T cells and macrophages.
Li D; Li Y; Wu X; Li Q; Yu J; Gen J; Zhang XL
J Immunol; 2008 Mar; 180(5):3158-65. PubMed ID: 18292539
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitisation of human glioma cells by inhibition of β1,6-GlcNAc branched N-glycans.
Shen L; Dong XX; Wu JB; Qiu L; Duan QW; Luo ZG
Tumour Biol; 2016 Apr; 37(4):4909-18. PubMed ID: 26526581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
